SEC Form D filing

Ascribe Bioscience Inc., 2025-10-15

An SEC Form D private-offering notice from Ithaca, NY, a $15,272,656 filer-stated offering target in Biotech. Filed 2025-10-15. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Ascribe Bioscience Inc. site↗ Verified via SEC Form D

Develops natural crop protection biofungicides derived from soil microbiome molecules, including its flagship product Phytalix.

Filed 2025-10-15Filed to raise $15,272,656First money in 2025-10-08Raised so far $15,019,027HQ (as filed) Ithaca, NYSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified ascribebio.com↗Named in the filing 5 executives & directors
Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source